Details for New Drug Application (NDA): 040436
NDA 040436 describes DEXTROAMPHETAMINE SULFATE, which is a drug marketed by Able, Actavis Elizabeth, Nesher Pharms, Pharmazone, Quagen, Specgx Llc, Strides Pharma, Strides Pharma Intl, Prasco, Tris Pharma Inc, Ani Pharms, Aurolife Pharma Llc, Avanthi Inc, Azurity, Barr, Epic Pharma Llc, Halsey, Lannett, Mast Mm, Novel Labs Inc, Nuvo Pharm, Purepac Pharm, Sandoz, Vitarine, and Winder Labs Llc, and is included in thirty-three NDAs. It is available from fourteen suppliers. Additional details are available on the DEXTROAMPHETAMINE SULFATE profile page.
The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There is one drug master file entry for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There is one drug master file entry for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
Summary for 040436
| Tradename: | DEXTROAMPHETAMINE SULFATE |
| Applicant: | Specgx Llc |
| Ingredient: | dextroamphetamine sulfate |
| Patents: | 0 |
Pharmacology for NDA: 040436
| Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for 040436
Suppliers and Packaging for NDA: 040436
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 040436 | ANDA | SpecGx LLC | 0406-8958 | 0406-8958-01 | 100 TABLET in 1 BOTTLE (0406-8958-01) |
| DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 040436 | ANDA | SpecGx LLC | 0406-8959 | 0406-8959-01 | 100 TABLET in 1 BOTTLE (0406-8959-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Jan 29, 2002 | TE: | AA | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Jan 29, 2002 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
